{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:12:46Z","timestamp":1793229166306,"version":"4.5.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138340","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T21:10:00Z","timestamp":1442956200000},"page":"e0138340","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":167,"title":["Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct01580007","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Akhirunnesa","family":"Mily","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokeya Sultana","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M. Mostafa","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Saleh Mohammad","family":"Arifuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeaur","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Ahsanul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaliqu","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Brighenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur H.","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Agerberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubhana","family":"Raqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"ref1","unstructured":"Organization WH. Global Tuberculosis Report 2014. France: World Health Organization, 2014 WHO\/HTM\/TB\/2014.08."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","article-title":"HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality","volume":"181","author":"NR Gandhi","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","article-title":"The looming co-epidemic of TB-diabetes: A call to action","author":"K L\u00f6nnroth","year":"2014","journal-title":"International Union Against Tuberculosis and Lung Disease"},{"key":"ref4","year":"2014"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tim.2013.05.002","article-title":"Rising to the challenge: new therapies for tuberculosis","volume":"21","author":"EB Wong","year":"2013","journal-title":"Trends Microbiol"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4049\/jimmunol.173.5.2909","article-title":"Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression","volume":"173","author":"TT Wang","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2567.2006.02399.x","article-title":"Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli","volume":"118","author":"J Schauber","year":"2006","journal-title":"Immunology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.2741\/2964","article-title":"The role of the multifunctional peptide LL-37 in host defense","volume":"13","author":"Y Kai-Larsen","year":"2008","journal-title":"Front Biosci"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/pathogens2010013","article-title":"Defensin production by human limbo-corneal fibroblasts infected with mycobacteria","volume":"2","author":"JI Castaneda-Sanchez","year":"2013","journal-title":"Pathogens"},{"issue":"5768","key":"ref10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"PT Liu","year":"2006","journal-title":"Science"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"PT Liu","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.chom.2009.08.004","article-title":"Vitamin D3 induces autophagy in human monocytes\/macrophages via cathelicidin","volume":"6","author":"JM Yuk","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/ije\/dym247","article-title":"Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis","volume":"37","author":"KE Nnoaham","year":"2008","journal-title":"Int J Epidemiol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0041-3879(85)90068-6","article-title":"A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis","volume":"66","author":"PD Davies","year":"1985","journal-title":"Tubercle"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0041-3879(85)90035-2","article-title":"A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis","volume":"66","author":"JM Grange","year":"1985","journal-title":"Tubercle"},{"key":"ref16","first-page":"554","article-title":"Tuberculosis and vitamin D deficiency","volume":"50","author":"PK Sasidharan","year":"2002","journal-title":"J Assoc Physicians India"},{"issue":"9761","key":"ref17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(10)61889-2","article-title":"High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial","volume":"377","author":"AR Martineau","year":"2011","journal-title":"Lancet"},{"key":"ref18","article-title":"Inflammation and tuberculosis: host-directed therapies","author":"A Zumla","year":"2014","journal-title":"J Intern Med"},{"issue":"7507","key":"ref19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature13489","article-title":"Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk","volume":"511","author":"KD Mayer-Barber","year":"2014","journal-title":"Nature"},{"issue":"4","key":"ref20","first-page":"e01534","article-title":"Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens","volume":"5","author":"DM Czyz","year":"2014","journal-title":"MBio"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.52.5.735","article-title":"Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways","volume":"52","author":"J Schauber","year":"2003","journal-title":"Gut"},{"issue":"24","key":"ref22","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.0602888103","article-title":"Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic","volume":"103","author":"R Raqib","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1067\/mpd.2001.111836","article-title":"Alternative pathway therapy for urea cycle disorders: twenty years later","volume":"138","author":"ML Batshaw","year":"2001","journal-title":"J Pediatr"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1128\/AAC.00818-09","article-title":"Phenylbutyrate induces antimicrobial peptide expression","volume":"53","author":"J Steinmann","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e20637","DOI":"10.1371\/journal.pone.0020637","article-title":"Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy","volume":"6","author":"P Sarker","year":"2011","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2466-13-23","article-title":"Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis","volume":"13","author":"A Mily","year":"2013","journal-title":"BMC Pulm Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1475-2891-12-47","article-title":"Randomized placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial","volume":"12","author":"DE Roth","year":"2013","journal-title":"Nutr J"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cncr.24749","article-title":"A phase 2 trial exploring the effects of high-dose (10,000 IU\/day) vitamin D(3) in breast cancer patients with bone metastases","volume":"116","author":"E Amir","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"ref29","first-page":"992","article-title":"Tuberculosis control in Bangladesh: success of the DOTS strategy","volume":"2","author":"JA Kumaresan","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00365540701558698","article-title":"TBscore: Signs and symptoms from tuberculosis patients in a low-resource setting have predictive value and may be used to assess clinical course","volume":"40","author":"C Wejse","year":"2008","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"ref31","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"G Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/thx.2010.136242","article-title":"A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis","volume":"65","author":"AP Ralph","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"ref33","article-title":"A Method for Visual Scoring of Pulmonary Mycobacterium Avium Complex Disease: \u201cNICE Scoring System\u201d","volume":"3","author":"A Kurashima","year":"2013","journal-title":"Mycobacterial Diseases"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1203\/00006450-200302000-00003","article-title":"Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense","volume":"53","author":"H Yoshio","year":"2003","journal-title":"Pediatr Res"},{"issue":"7","key":"ref35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1462-5822.2005.00530.x","article-title":"Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37","volume":"7","author":"P Bergman","year":"2005","journal-title":"Cell Microbiol"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1373\/clinchem.2004.031831","article-title":"Candidate reference method for the quantification of circulating 25-hydroxyvitamin D3 by liquid chromatography-tandem mass spectrometry","volume":"50","author":"M Vogeser","year":"2004","journal-title":"Clin Chem"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"511S","DOI":"10.1093\/ajcn\/88.2.511S","article-title":"Development of a standard reference material for vitamin D in serum","volume":"88","author":"KW Phinney","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"ref38","unstructured":"Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ods.od.nih.gov\/Research\/vdsp.aspx\" xlink:type=\"simple\">http:\/\/ods.od.nih.gov\/Research\/vdsp.aspx<\/ext-link> hwngmcvc."},{"key":"ref39","unstructured":"Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/labstandards\/vitaleqa_about.html\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/labstandards\/vitaleqa_about.html<\/ext-link>."},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"AC Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1183\/09031936.03.00090702","article-title":"Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis","volume":"21","author":"T Schon","year":"2003","journal-title":"Eur Respir J"},{"key":"ref42","first-page":"0","article-title":"Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages","author":"RS Rekha","year":"2015","journal-title":"Autophagy"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"e1005007","DOI":"10.1371\/journal.ppat.1005007","article-title":"Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D(3)","volume":"11","author":"AK Coussens","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From Monocytes to M1\/M2 Macrophages: Phenotypical vs. Functional Differentiation","volume":"5","author":"P Italiani","year":"2014","journal-title":"Front Immunol"},{"issue":"9","key":"ref45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"RE Hancock","year":"2000","journal-title":"Trends Microbiol"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.4049\/jimmunol.1000376","article-title":"LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature","volume":"185","author":"AM van der Does","year":"2010","journal-title":"J Immunol"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.4049\/jimmunol.179.11.7684","article-title":"Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways","volume":"179","author":"J Yu","year":"2007","journal-title":"J Immunol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2013.03.024","article-title":"Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes","volume":"433","author":"X Chen","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1189\/jlb.0513304","article-title":"Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages","volume":"95","author":"M Wan","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.169.7.3883","article-title":"The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses","volume":"169","author":"MG Scott","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action","volume":"281","author":"Y Rosenfeld","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.178.3.1829","article-title":"Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization","volume":"178","author":"A Di Nardo","year":"2007","journal-title":"J Immunol"},{"issue":"9","key":"ref53","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.4049\/jimmunol.1002508","article-title":"Host defense peptide LL-37 selectively reduces proinflammatory macrophage responses","volume":"186","author":"KL Brown","year":"2011","journal-title":"J Immunol"},{"issue":"8","key":"ref54","doi-asserted-by":"crossref","first-page":"e70032","DOI":"10.1371\/journal.pone.0070032","article-title":"L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial","volume":"8","author":"AP Ralph","year":"2013","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-13-22","article-title":"Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis&apos;","volume":"13","author":"N Salahuddin","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.200804-567OC","article-title":"Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial","volume":"179","author":"C Wejse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200701-007OC","article-title":"A single dose of vitamin D enhances immunity to mycobacteria","volume":"176","author":"AR Martineau","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"e65835","DOI":"10.1371\/journal.pone.0065835","article-title":"Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"8","author":"P Bergman","year":"2013","journal-title":"PLoS One"},{"issue":"9824","key":"ref59","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(12)60405-X","article-title":"Bolus-dose vitamin D and prevention of childhood pneumonia","volume":"379","author":"AR Martineau","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri3813","article-title":"Advancing host-directed therapy for tuberculosis","volume":"15","author":"RS Wallis","year":"2015","journal-title":"Nat Rev Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T04:49:31Z","timestamp":1718081371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138340"}},"subtitle":[],"editor":[{"given":"Nerges","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138340","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}